Daehan Shipbuilding Co., Ltd. (KRX:439260)

Aerovate Therapeutics Statistics

Total Valuation

KRX:439260 has a market cap or net worth of KRW 3.56 trillion. The enterprise value is 3.44 trillion.

Market Cap	3.56T
Enterprise Value	3.44T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KRX:439260 has 38.53 million shares outstanding. The number of shares has decreased by -43.86% in one year.

Current Share Class	38.53M
Shares Outstanding	38.53M
Shares Change (YoY)	-43.86%
Shares Change (QoQ)	+8.78%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	24.89%
Float	20.16M

Valuation Ratios

The trailing PE ratio is 13.20.

PE Ratio	13.20
Forward PE	n/a
PS Ratio	3.04
PB Ratio	6.93
P/TBV Ratio	6.94
P/FCF Ratio	12.17
P/OCF Ratio	11.92
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.04, with an EV/FCF ratio of 11.77.

EV / Earnings	16.27
EV / Sales	2.94
EV / EBITDA	16.04
EV / EBIT	17.01
EV / FCF	11.77

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.52.

Current Ratio	1.18
Quick Ratio	0.54
Debt / Equity	0.52
Debt / EBITDA	1.24
Debt / FCF	0.91
Interest Coverage	10.54

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	35.27%
Revenue Per Employee	2.19B
Profits Per Employee	394.47M
Employee Count	536
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-4.27B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	5,375,746

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:439260 had revenue of KRW 1.17 trillion and earned 211.44 billion in profits. Earnings per share was 6,997.49.

Revenue	1.17T
Gross Profit	226.64B
Operating Income	202.32B
Pretax Income	207.17B
Net Income	211.44B
EBITDA	214.46B
EBIT	202.32B
Earnings Per Share (EPS)	6,997.49

Balance Sheet

The company has 385.48 billion in cash and 266.20 billion in debt, giving a net cash position of 119.28 billion or 3,096.15 per share.

Cash & Cash Equivalents	385.48B
Total Debt	266.20B
Net Cash	119.28B
Net Cash Per Share	3,096.15
Equity (Book Value)	514.00B
Book Value Per Share	16,837.80
Working Capital	144.42B

Cash Flow

In the last 12 months, operating cash flow was 298.69 billion and capital expenditures -6.25 billion, giving a free cash flow of 292.43 billion.

Operating Cash Flow	298.69B
Capital Expenditures	-6.25B
Free Cash Flow	292.43B
FCF Per Share	7,590.49

Margins

Gross margin is 19.35%, with operating and profit margins of 17.27% and 18.05%.

Gross Margin	19.35%
Operating Margin	17.27%
Pretax Margin	17.68%
Profit Margin	18.05%
EBITDA Margin	18.31%
EBIT Margin	17.27%
FCF Margin	24.96%

Dividends & Yields

KRX:439260 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	43.86%
Shareholder Yield	n/a
Earnings Yield	5.94%
FCF Yield	8.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:439260 has an Altman Z-Score of 1.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.77
Piotroski F-Score	5